Literature DB >> 7816797

Sequential induction of 5-lipoxygenase gene expression and activity in Mono Mac 6 cells by transforming growth factor beta and 1,25-dihydroxyvitamin D3.

M Brungs1, O Rådmark, B Samuelsson, D Steinhilber.   

Abstract

5-Lipoxygenase (5-LO; EC 1.13.11.34) activity in the human monocytic cell line Mono Mac 6 was upregulated by combined treatment with transforming growth factor beta 1 (TGF-beta) and 1,25-dihydroxyvitamin D3 (VD3). In undifferentiated cells, 5-LO enzyme activity was undetectable. After the addition of TGF-beta plus VD3, the activity of intact cells was 800 ng per 10(6) cells--500 times more than the assay detection limit. Also 5-LO protein and mRNA expression were induced > 128-fold and 64-fold, respectively, as compared to undifferentiated cells. Both TGF-beta and VD3 were required for these prominent responses. Either agent alone gave small amounts of 5-LO protein and mRNA but very low 5-LO activities. After the addition of TGF-beta and VD3, the induction of 5-LO protein was obvious after 1 day, but the increase in activity was delayed and did not appear until the second day. Pretreatment of cells with TGF-beta or VD3 alone for 2 days led to 5-LO protein expression but very low enzyme activity. Addition of the lacking second inducer was required for full induction of 5-LO protein expression and for upregulation of enzyme activity. Partial purification of 5-LO from Mono Mac 6 cells and recombination with soluble cellular proteins from different sources indicated the presence of cytosolic factors that affect the activity of 5-LO.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7816797      PMCID: PMC42826          DOI: 10.1073/pnas.92.1.107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  Effects of combining transforming growth factor beta and 1,25-dihydroxyvitamin D3 on differentiation of a human osteosarcoma (MG-63).

Authors:  L F Bonewald; M B Kester; Z Schwartz; L D Swain; A Khare; T L Johnson; R J Leach; B D Boyan
Journal:  J Biol Chem       Date:  1992-05-05       Impact factor: 5.157

2.  Expression of 5-lipoxygenase and biosynthesis of leukotriene B4 in human monomorphonuclear leukocytes.

Authors:  H E Claesson; P J Jakobsson; D Steinhilber; B Odlander; B Samuelsson
Journal:  J Lipid Mediat       Date:  1993 Mar-Apr

3.  1,25-Dihydroxyvitamin D3 upregulates 5-lipoxygenase metabolism and 5-lipoxygenase activating protein in peripheral blood monocytes as they differentiate into mature macrophages.

Authors:  M J Coffey; M Gyetko; M Peters-Golden
Journal:  J Lipid Mediat       Date:  1993 Mar-Apr

4.  Correlation between expression of 5-lipoxygenase-activating protein, 5-lipoxygenase, and cellular leukotriene synthesis.

Authors:  G K Reid; S Kargman; P J Vickers; J A Mancini; C Léveillé; D Ethier; D K Miller; J W Gillard; R A Dixon; J F Evans
Journal:  J Biol Chem       Date:  1990-11-15       Impact factor: 5.157

5.  Serum factors regulate 5-lipoxygenase activity in maturating HL60 cells.

Authors:  D Steinhilber; S Hoshiko; J Grunewald; O Rådmark; B Samuelsson
Journal:  Biochim Biophys Acta       Date:  1993-07-28

6.  Transforming growth factor beta upregulates 5-lipoxygenase activity during myeloid cell maturation.

Authors:  D Steinhilber; O Rådmark; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

7.  Alveolar macrophages have greater amounts of the enzyme 5-lipoxygenase than do monocytes.

Authors:  R J Pueringer; C C Bahns; G W Hunninghake
Journal:  J Appl Physiol (1985)       Date:  1992-08

8.  Transforming growth factor-beta potentiates vitamin D3-induced terminal monocytic differentiation of human leukemic cell lines.

Authors:  U Testa; R Masciulli; E Tritarelli; R Pustorino; G Mariani; R Martucci; T Barberi; A Camagna; M Valtieri; C Peschle
Journal:  J Immunol       Date:  1993-03-15       Impact factor: 5.422

9.  Regulation of 5-lipoxygenase and 5-lipoxygenase-activating protein expression in HL-60 cells.

Authors:  C F Bennett; M Y Chiang; B P Monia; S T Crooke
Journal:  Biochem J       Date:  1993-01-01       Impact factor: 3.857

10.  Iron content of human 5-lipoxygenase, effects of mutations regarding conserved histidine residues.

Authors:  Y Y Zhang; B Lind; O Rådmark; B Samuelsson
Journal:  J Biol Chem       Date:  1993-02-05       Impact factor: 5.157

View more
  24 in total

1.  Electrophilic fatty acid species inhibit 5-lipoxygenase and attenuate sepsis-induced pulmonary inflammation.

Authors:  Khader Awwad; Svenja D Steinbrink; Timo Frömel; Nicole Lill; Johann Isaak; Ann-Kathrin Häfner; Jessica Roos; Bettina Hofmann; Heinrich Heide; Gerd Geisslinger; Dieter Steinhilber; Bruce A Freeman; Thorsten J Maier; Ingrid Fleming
Journal:  Antioxid Redox Signal       Date:  2014-02-03       Impact factor: 8.401

2.  Antiinflammatory potential of lipoxygenase-derived eicosanoids: a molecular switch at 5 and 15 positions?

Authors:  C N Serhan; J M Drazen
Journal:  J Clin Invest       Date:  1997-03-15       Impact factor: 14.808

3.  5-lipoxygenase is phosphorylated by p38 kinase-dependent MAPKAP kinases.

Authors:  O Werz; J Klemm; B Samuelsson; O Rådmark
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

4.  Dual-target virtual screening by pharmacophore elucidation and molecular shape filtering.

Authors:  Daniel Moser; Joanna M Wisniewska; Steffen Hahn; Janosch Achenbach; Estel la Buscató; Franca-Maria Klingler; Bettina Hofmann; Dieter Steinhilber; Ewgenij Proschak
Journal:  ACS Med Chem Lett       Date:  2012-01-17       Impact factor: 4.345

5.  Dioxin-induced increase in leukotriene B4 biosynthesis through the aryl hydrocarbon receptor and its relevance to hepatotoxicity owing to neutrophil infiltration.

Authors:  Tomoki Takeda; Yukiko Komiya; Takayuki Koga; Takumi Ishida; Yuji Ishii; Yasushi Kikuta; Michio Nakaya; Hitoshi Kurose; Takehiko Yokomizo; Takao Shimizu; Hiroshi Uchi; Masutaka Furue; Hideyuki Yamada
Journal:  J Biol Chem       Date:  2017-05-09       Impact factor: 5.157

6.  Exploring the chemical space of multitarget ligands using aligned self-organizing maps.

Authors:  Janosch Achenbach; Franca-Maria Klingler; René Blöcher; Daniel Moser; Ann-Kathrin Häfner; Carmen B Rödl; Simon Kretschmer; Björn Krüger; Frank Löhr; Holger Stark; Bettina Hofmann; Dieter Steinhilber; Ewgenij Proschak
Journal:  ACS Med Chem Lett       Date:  2013-10-23       Impact factor: 4.345

7.  Regulation of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase-activating protein/5-lipoxygenase by 4-hydroxynonenal in human osteoarthritic chondrocytes.

Authors:  Shu-Huang Chen; Hassan Fahmi; Qin Shi; Mohamed Benderdour
Journal:  Arthritis Res Ther       Date:  2010-02-09       Impact factor: 5.156

8.  Molecular pharmacological profile of the nonredox-type 5-lipoxygenase inhibitor CJ-13,610.

Authors:  Lutz Fischer; Dieter Steinhilber; Oliver Werz
Journal:  Br J Pharmacol       Date:  2004-06-14       Impact factor: 8.739

9.  Sulindac sulfide suppresses 5-lipoxygenase at clinically relevant concentrations.

Authors:  Svenja D Steinbrink; Carlo Pergola; Ulrike Bühring; Sven George; Julia Metzner; Astrid S Fischer; Ann-Kathrin Häfner; Joanna M Wisniewska; Gerd Geisslinger; Oliver Werz; Dieter Steinhilber; Thorsten J Maier
Journal:  Cell Mol Life Sci       Date:  2009-11-29       Impact factor: 9.261

10.  Roles of coactosin-like protein (CLP) and 5-lipoxygenase-activating protein (FLAP) in cellular leukotriene biosynthesis.

Authors:  Devaraj Basavarajappa; Min Wan; Ana Lukic; Dieter Steinhilber; Bengt Samuelsson; Olof Rådmark
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.